Total Payments
$8,668
2024 Payments
$493.80
Companies
33
Transactions
181
Medicare Patients
3,120
Medicare Billing
$311,592
Payment Breakdown by Category
Other$4,875 (56.2%)
Food & Beverage$3,786 (43.7%)
Education$6.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $4,875 | 1 | 56.2% |
| Food and Beverage | $3,786 | 179 | 43.7% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $4,875 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $497.21 | 25 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $392.64 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $360.18 | 15 | $0 (2023) |
| Boston Scientific Corporation | $330.51 | 18 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $264.86 | 17 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $258.58 | 16 | $0 (2021) |
| Amarin Pharma Inc. | $240.42 | 3 | $0 (2019) |
| Merck Sharp & Dohme LLC | $157.74 | 8 | $0 (2022) |
| Cardiovascular Systems Inc. | $132.38 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $493.80 | 18 | Novartis Pharmaceuticals Corporation ($243.73) |
| 2023 | $172.16 | 10 | Novartis Pharmaceuticals Corporation ($130.87) |
| 2022 | $5,177 | 16 | AngioDynamics, Inc. ($4,875) |
| 2021 | $505.83 | 27 | Merck Sharp & Dohme Corporation ($88.66) |
| 2020 | $319.56 | 18 | Janssen Pharmaceuticals, Inc ($70.16) |
| 2019 | $676.76 | 31 | Janssen Pharmaceuticals, Inc ($137.32) |
| 2018 | $683.27 | 32 | AstraZeneca Pharmaceuticals LP ($115.01) |
| 2017 | $639.60 | 29 | E.R. Squibb & Sons, L.L.C. ($148.75) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: EndoVenous Therapies | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $58.25 | General |
| Category: Cardiovascular Device | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $126.69 | General |
| 04/15/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: NEUROLOGY | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: WATCHMAN_IC | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/26/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.97 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,249 | 1,992 | $493,869 | $139,535 |
| 2022 | 14 | 835 | 961 | $265,851 | $82,049 |
| 2021 | 6 | 479 | 581 | $152,582 | $42,134 |
| 2020 | 5 | 557 | 706 | $172,028 | $47,874 |
Total Patients
3,120
Total Services
4,240
Medicare Billing
$311,592
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 53 | 53 | $39,273 | $7,844 | 20.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 37 | 37 | $25,678 | $5,585 | 21.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $20,500 | $5,517 | 26.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 22 | 22 | $20,526 | $4,196 | 20.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 25 | 25 | $9,250 | $3,556 | 38.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 32 | 33 | $8,250 | $3,091 | 37.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 40 | 43 | $7,482 | $2,757 | 36.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 116 | 119 | $5,578 | $1,259 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,760 | $1,064 | 22.4% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2022 | 12 | 12 | $3,180 | $1,023 | 32.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2022 | 17 | 17 | $1,105 | $341.55 | 30.9% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2022 | 17 | 17 | $629.00 | $184.96 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 264 | 359 | $79,420 | $21,353 | 26.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 79 | 79 | $43,032 | $12,782 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 64 | $20,535 | $5,627 | 27.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $7,112 | $1,905 | 26.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 37 | 37 | $2,183 | $394.83 | 18.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 25 | 25 | $300.00 | $72.00 | 24.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 322 | 462 | $83,210 | $22,872 | 27.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 81 | 81 | $41,472 | $12,509 | 30.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 128 | 137 | $36,370 | $9,546 | 26.2% |
| 36589 | Removal of central venous catheter for infusion | Office | 2020 | 14 | 14 | $6,020 | $1,590 | 26.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $4,956 | $1,357 | 27.4% |
About Dr. Wallace Lai, MD
Dr. Wallace Lai, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578503249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wallace Lai, MD has received a total of $8,668 in payments from pharmaceutical and medical device companies, with $493.80 received in 2024. These payments were reported across 181 transactions from 33 companies. The most common payment nature is "Long term medical supply or device loan" ($4,875).
As a Medicare-enrolled provider, Lai has provided services to 3,120 Medicare beneficiaries, totaling 4,240 services with total Medicare billing of $311,592. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Salem, OR
- Active Since 06/08/2006
- Last Updated 09/01/2015
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1578503249
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $4,875
- XARELTO (Drug) $497.21
- ELIQUIS (Drug) $467.23
- LEQVIO (Drug) $247.84
- Vascepa (Drug) $240.42
- BRILINTA (Drug) $196.56
- VERQUVO (Drug) $157.74
- ENTRESTO (Drug) $144.80
- Peripheral Orbital Atherectomy System (Device) $132.38
- Repatha (Biological) $91.60
- FLUENCY (Device) $80.71
- CROSSER (Device) $66.60
- COYOTE (Device) $65.70
- FARXIGA (Drug) $62.02
- Optimizer (Device) $58.25
- INNOVA (Device) $58.15
- VENASEAL (Device) $47.75
- ENROUTE Transcarotid Neuroprotection System (Device) $45.00
- Rotarex (Device) $41.61
- LIFESTENT (Device) $34.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.